| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 22.6k | $0.00 | $0 | | 08/11/2023 |
| 08/11/2023 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 11.2k | $18.91 | $212.1k | | 08/11/2023 |
| 07/03/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 1.7k | $25.04 | $42.6k | | 06/30/2023 |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 769 | $15.61 | $12k | | 06/30/2023 |
| 06/02/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 500 | $31.00 | $15.5k | | 06/01/2023 |
| 06/01/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 2.7k | $30.57 | $82.6k | | 06/01/2023 |
| 05/15/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 21.4k | $34.55 | $739.3k | | 02/02/2022 |
| 04/03/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 3.2k | $32.15 | $102.9k | | 04/03/2023 |
| 03/15/2023 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 3.7k | $30.65 | $114.6k | | 03/15/2023 |
| 03/09/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 18.5k | $31.59 | $584.9k | | 09/22/2022 |
| 03/01/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 3.2k | $33.50 | $107.2k | | 03/01/2023 |
| 01/20/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 1000 | $31.00 | $31k | | 01/20/2023 |
| 01/09/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 1.7k | $25.00 | $42.5k | | 01/09/2023 |
| 01/09/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 1000 | $28.00 | $28k | | 01/09/2023 |
| 01/09/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 1000 | $30.00 | $30k | | 01/09/2023 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 645 | $12.18 | $7.9k | | 12/31/2022 |
| 12/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 1.6k | $21.50 | $33.5k | | 12/15/2022 |
| 09/22/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 42.3k | $0.00 | $0 | | 09/22/2022 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 965 | $11.75 | $11.3k | | 06/30/2022 |
| 03/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2.6k | $15.79 | $41.2k | | 03/15/2022 |
| 02/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2.2k | $13.35 | $29.9k | | 02/15/2022 |
| 02/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 683 | $13.35 | $9.1k | | 02/15/2022 |
| 02/02/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 42.3k | $0.00 | $0 | | 02/02/2022 |
| 02/02/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 68.1k | $13.08 | $890.7k | | 02/02/2022 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 404 | $13.87 | $5.6k | | 12/31/2021 |
| 12/15/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 1.6k | $15.92 | $24.8k | | 12/15/2021 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 446 | $24.09 | $10.7k | | 06/30/2021 |
| 02/15/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 684 | $28.97 | $19.8k | | 02/15/2021 |
| 02/15/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2k | $28.97 | $57.2k | | 02/15/2021 |
| 02/02/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 22.6k | $0.00 | $0 | | 02/02/2021 |
| 02/02/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 40.9k | $28.01 | $1.1M | | 02/02/2021 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 493 | $21.36 | $10.5k | | 12/31/2020 |
| 12/15/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 1.6k | $26.75 | $41.6k | | 12/15/2020 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 15.8k | $0.00 | $0 | | 09/30/2020 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 5.4k | $25.14 | $136.9k | | 09/30/2020 |
|